ANNEXON SUBMITS TANRUPRUBART MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR GUILLAIN-BARRÉ SYNDROME

Reuters · 5d ago

Please log in to view news